Brandon Sawalich, President and CEO of Starkey, returns to discuss the recently released FDA proposed rule for Over The Counter (OTC) hearing aids, as well as the new Medicare Hearing Benefit currently under consideration in Congress as part of a larger spending package. In its current form, the Medicare benefit includes a provision to provide hearing aid coverage for those with severe hearing loss every 5 years.   

The pair discuss the implications of both the draft OTC rule, as well as the Medicare benefit, on patients, providers and the overall industry.

Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter: